OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Having a clear clinical strategy early on can shave time off overall development projects.
Complex hurdles complicate the development of emerging therapies.
Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.
September 16, 2022
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
September 15, 2022
Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
The growth of the biopharmaceuticals market is feeding back into economies and, in part, is driving the boom in life sciences and biotech ecosystems.
September 14, 2022
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
September 02, 2022
While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.
The projected growth in the biosimilars market will require increased bulk mAb manufacturing.
September 01, 2022
Scaling up chromatography resins requires a thorough understanding of their intended use.
August 31, 2022
Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.
August 30, 2022
Scientists have developed a mouse model that could be a promising model system for research into factors affecting mammalian embryonic development and disease.
August 22, 2022
ProBioGen will collobarate with NextPoint Therapeutics to develop and manufacture its lead antibody candidate.